Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Masanori Kurokawa"'
Autor:
Masanori Kurokawa
Publikováno v:
Axoplasmic Transport ISBN: 9781351070003
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::231ce5ded556ff26c52269c4e19e31ca
https://doi.org/10.1201/9781351070003-7
https://doi.org/10.1201/9781351070003-7
Autor:
Yasuharu Imai, Masanori Kurokawa, Masanori Nakahara, Hideko Ohama, Norihiko Fujita, Masatoshi Hori, Yoshiyuki Sawai, Shinichiro Zushi, Yuki Makino, Kazuto Fukuda, Takamichi Murakami, Sachiyo Kogita, Manabu Takamura, Takumi Igura, Keisuke Isotani, Yasushi Matsumoto
Publikováno v:
Hepatology Research. 43:950-958
Aim To demonstrate the usefulness of the computed tomography (CT) fusion imaging for the evaluation of treatment effect of radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). Methods Eighty-five patients with 94 HCC with complete ablati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ebefda06de0619040a2b08a3b79c853
https://doi.org/10.1111/hepr.12049
https://doi.org/10.1111/hepr.12049
Autor:
Naoto Uenoyama, Masanori Kurokawa, Kiyonori Yuguchi, Shin-ichirou Zushi, Yasushi Matsumoto, Yoshiyuki Sawai, Yasuharu Imai, Kouichi Tachibana, Sachiyo Kogita, Seriko Ikezoe, Hirotugu Katsuno, Akira Mukai, Kazuto Fukuda, Masanori Nakahara
Publikováno v:
Kanzo. 49:72-76
症例は79歳男性．他院にて，平成10年より洞不全症候群（Rubenstein I型）に対しDDDR型ペースメーカーの加療を受けている．同時期よりC型慢性肝炎を指摘され，平成15年肝S7の11mm大の肝細胞
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5eed21a048380d124634d382eea0df71
https://doi.org/10.2957/kanzo.49.72
https://doi.org/10.2957/kanzo.49.72
Autor:
Mineo Hasegawa, Yasuhiko Homma, Yasunobu Masuda, Michihiro Sugano, Mika Usuda, Masanori Kurokawa, Mitsuhiro Noda, Sayaka Takeda
Publikováno v:
Journal of Oleo Science. 57:35-45
In a placebo-controlled double-blind study, we examined the effects of dressing containing plant sterol (PS) on blood lipids and the safety in Japanese borderline or mildly hypercholesterolemic subjects. Fifty-nine subjects [total cholesterol (TC) co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fbb7fa83d5fd43d71d7e7de26d71365
https://doi.org/10.5650/jos.57.35
https://doi.org/10.5650/jos.57.35
Autor:
Takuya Yamada, Seiko Tsujino, Takamasa Yabuta, Shinichiro Zushi, Kazuto Fukuda, Yasuharu Imai, Masanori Kurokawa
Publikováno v:
Digestive Endoscopy. 17:32-35
Background: Gastric antral vascular ectasia (GAVE) is an uncommon but treatable cause of chronic gastrointestinal bleeding often associated with severe cirrhosis. Efficacy of endoscopic treatment is well known; however, long-term outcome after endosc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41e76e171da59da60feb28ab568d1dec
https://doi.org/10.1111/j.1443-1661.2005.00426.x
https://doi.org/10.1111/j.1443-1661.2005.00426.x
Autor:
Yuriko Kono, Hideo Tanaka, Akiko Tujino, Mamoru Hayashi, Kenichi Nishi, Takamasa Yabuta, Kazuto Fukuda, Shinichiro Zushi, Yasuharu Imai, Masanori Kurokawa
Publikováno v:
Kanzo. 45:232-238
大阪府池田市, 豊能町における平成14年度老人保健法に基づく健康診査のHCV検診の現況を報告する. 本地域において平成14年度に3478名 (男性1067名, 女性2411名) がHCV抗体検査を受けた. 受診者
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b00c060131830be31c8fa51f06dc5865
https://doi.org/10.2957/kanzo.45.232
https://doi.org/10.2957/kanzo.45.232
Autor:
Hitoshi MATSUMOTO, Yasuharu IMAI, Kazuto FUKUDA, Shin-ichiro ZUSHI, Takamasa YABUTA, Yasushi MATSUMOTO, Koji NAKATANI, Juichi FUKUSHIMA, Takuya YAMADA, Masanori KUROKAWA, Shiro ADACHI
Publikováno v:
Kanzo. 44:139-144
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0f8d30baf24d0ed17482eeec87b9882
https://doi.org/10.2957/kanzo.44.139
https://doi.org/10.2957/kanzo.44.139
Autor:
Takumi Igura, Nobuyuki Kajiwara, Yasushi Matsumoto, Masanori Nakahara, Shinichiro Zushi, Tomohide Kurahashi, Kazuyuki Hayashi, Satoko Yamamoto, Yasuharu Imai, Masanori Kurokawa
Publikováno v:
Nihon Naika Gakkai Zasshi. 100:1657-1659
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85944b1d9a3a4d7413550144762575fa
https://doi.org/10.2169/naika.100.1657
https://doi.org/10.2169/naika.100.1657
Autor:
Takumi Igura, Sachiyo Kogita, Masanori Kurokawa, Hideko Ohama, Yoshiyuki Sawai, Yuki Makino, Yukiko Sumimura, Kazuto Fukuda, Yasuharu Imai, Chika Ohata
Publikováno v:
Kanzo. 52:787-789
Sorafenib is a newly approved multikinase inhibitor for the treatment of unresectable hepatocellular carcinoma (HCC) and advanced renal cell carcinoma. Sorafenib is associated with a relatively high incidence of cutaneous adverse events. We report th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e513a26b002427b3cc532bf5d5900e3
https://doi.org/10.2957/kanzo.52.787
https://doi.org/10.2957/kanzo.52.787